{"id":"NCT01333111","sponsor":"Novo Nordisk A/S","briefTitle":"Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients","officialTitle":"A Multi-centre, Single-blind Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC-0156-0000-0009 When Used for Treatment and Prophylaxis of Bleeding Episodes in Patients With Haemophilia B","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04-27","primaryCompletion":"2013-03-31","completion":"2013-03-31","firstPosted":"2011-04-11","resultsPosted":"2017-07-28","lastUpdate":"2017-07-28"},"enrollment":74,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Congenital Bleeding Disorder","Haemophilia B"],"interventions":[{"type":"DRUG","name":"nonacog beta pegol","otherNames":["NNC-0156-0000-0009"]},{"type":"DRUG","name":"nonacog beta pegol","otherNames":["NNC-0156-0000-0009"]},{"type":"DRUG","name":"nonacog beta pegol","otherNames":["NNC-0156-0000-0009"]}],"arms":[{"label":"Prophylaxis, high dose (trial duration 52 weeks)","type":"EXPERIMENTAL"},{"label":"Prophylaxis, low dose (trial duration 52 weeks)","type":"EXPERIMENTAL"},{"label":"On-demand (trial duration 28 weeks)","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Africa, Asia, Europe, Japan and North America. The aim of this trial is to evaluate the safety and efficacy, including pharmacokinetics (the rate at which the body eliminates the trial drug), of NNC-0156-0000-0009 (nonacog beta pegol) when used for treatment and prophylaxis of bleeding episodes in patients with haemophilia B.","primaryOutcome":{"measure":"Incidence of Inhibitory Antibodies Against Factor IX Defined as Titre Equal to or Above 0.6 BU (Bethesda Units)","timeFrame":"52 weeks after treatment start for patients on prophylaxis","effectByArm":[{"arm":"Prophylaxis, Low Dose 10 U/kg (52 Weeks)","deltaMin":0,"sd":null},{"arm":"Prophylaxis, High Dose 40 U/kg (52 Weeks)","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"13 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":43,"countries":["United States","Canada","France","Germany","Hungary","Italy","Japan","Malaysia","Netherlands","North Macedonia","Russia","South Africa","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["25261199"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":30},"commonTop":["Nasopharyngitis","Influenza","Upper respiratory tract infection","Headache","Fatigue"]}}